Abdel-Razeq H & Sharaf B. (2022). Expanding the Clinical Use of CDK4/6 Inhibitors in the Treatment of Hormone Receptor-Positive, HER2-Negative Breast Cancer from Metastatic Setting to Adjuvant Setting. Dove Medical Press.
Chicago Style (17th ed.) CitationAbdel-Razeq H and Sharaf B. Expanding the Clinical Use of CDK4/6 Inhibitors in the Treatment of Hormone Receptor-Positive, HER2-Negative Breast Cancer from Metastatic Setting to Adjuvant Setting. Dove Medical Press, 2022.
MLA (9th ed.) CitationAbdel-Razeq H and Sharaf B. Expanding the Clinical Use of CDK4/6 Inhibitors in the Treatment of Hormone Receptor-Positive, HER2-Negative Breast Cancer from Metastatic Setting to Adjuvant Setting. Dove Medical Press, 2022.
Warning: These citations may not always be 100% accurate.